Sensydia Corporation

Sensydia Corporation, based in Los Angeles, is dedicated to advancing cardiovascular and critical patient care by addressing the limitations of acquiring vital hemodynamic measurements. Their flagship product, the Cardiac Performance System (CPS), offers a non-invasive, automated platform that delivers accuracy comparable to gold-standard measures, facilitating rapid assessment of key cardiovascular metrics.

The CPS is designed for use in hospitals, medical offices, and various point-of-care settings, enabling healthcare providers to make informed decisions about patient care without the need for specialized equipment. By simplifying access to advanced hemodynamic measurements, Sensydia aims to improve patient outcomes, reduce readmissions, and lower healthcare costs for conditions such as heart failure and sepsis.

Generated from the website